Singapore - English - HSA (Health Sciences Authority)

b. braun singapore pte ltd - etomidate - injection - 20 mg/10 ml - etomidate 20 mg/10 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - etomidate - emulsion for injection - 2mg/1ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - etomidate 20 mg/10 ml - emulsion for injection - 20 mg/10 ml - etomidate 2 mg/ml - etomidate

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - cythioate - oral tablet - cythioate organophosphorus active 30.0 mg/tb - parasiticides - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - demodectic mange | flea | paralysis tick | australian paralysis tick | ctenocephalides spp. | ground fleas | scrub tick

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medice uk ltd - methylphenidate hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medice uk ltd - methylphenidate hydrochloride - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pilsco ltd - methylphenidate hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pilsco ltd - methylphenidate hydrochloride - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pilsco ltd - estradiol valerate - oral tablet - 1mg

European Union - English - EMA (European Medicines Agency)

fondazione telethon ets - autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ada) cdna sequence from human haematopoietic stem/progenitor (cd34+) cells - severe combined immunodeficiency - immunostimulants, - strimvelis is indicated for the treatment of patients with severe combined immunodeficiency due to adenosine deaminase deficiency (ada-scid), for whom no suitable human leukocyte antigen (hla)-matched related stem cell donor is available (see section 4.2 and section 4.4).